£16m to speed up diagnoses for life-threatening diseases

Patients could receive earlier and more accurate diagnoses for potentially life-threatening diseases, such as cancer and Crohn’s disease, thanks to £16 million of new funding.

Science Minister Amanda Solloway said that the government backed funding, delivered to six of the UK’s most innovative specialist health projects, will harness the most disruptive technologies, including artificial intelligence, to develop more precise medical solutions, which could enable earlier detection and diagnosis of some of the most serious and potentially fatal diseases.

Of the £16 million awarded today, over £13 million will be delivered by the government, while up to £3 million will be made available from Cancer Research UK, to specifically support the oncology focused projects.

Solloway said: “Our brilliant scientists and researchers are harnessing world-leading technologies, like AI, to tackle some of the most complex and chronic diseases that we face. Tragically, we know that one in two people in the UK will be diagnosed with some form of cancer during their lifetime, while Crohn’s disease affects up to 180,000 people across the country. These six cutting-edge projects will improve early diagnosis, create more precise treatments, and crucially, save lives.”

One project, led by the University of Oxford, is working to improve survival rates in people with lung cancer, the deadliest form of cancer in the UK. It will bring together existing work being led by the NHS, universities, cancer charities and digital health companies to integrate the best of digital imaging and diagnostic science to help identify cancerous tumours in the lung earlier.

Another, led by technology start up Motilent, is working on healthcare solutions to more effectively treat Crohn’s disease, a painful, lifelong inflammatory condition affecting 180,000 people in the UK. Through the use of artificial intelligence, it will seek to accurately predict when to start and stop drug use to control the disease, which currently has a 60 per cent failure rate, and which can lead to further, irreversible damage to a patient’s bowel.

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho